Nano-X Imaging (NASDAQ:NNOX) Releases Earnings Results, Misses Estimates By $0.63 EPS

Nano-X Imaging (NASDAQ:NNOX - Get Free Report) issued its earnings results on Wednesday, September 9th. The company reported ($0.79) EPS for the quarter, missing the consensus estimate of ($0.16) by ($0.63), Zacks reports. The firm had revenue of $4.16 million during the quarter, compared to analyst estimates of $5.38 million. Nano-X Imaging had a negative net margin of 926.05% and a negative return on equity of 116.93%.

Here are the key takeaways from Nano-X Imaging's conference call:

• Commercialization expanded with Nanox.ARC installations at RadNet, an orthopedic IDN, urgent care, and the first Nanox Imaging Network site in Philadelphia; the company reported some sites completing hundreds of scans monthly and 10 U.S. distribution partnerships.
• The Nanox Imaging Network has begun receiving insurer payments of approximately $200–$700 per claim, while management estimates potential annual revenue of roughly $500,000 to $1 million per site depending on utilization and reimbursement. A new CMS code for AI analysis of coronary and aortic valve calcification may also support Nanox.AI adoption.
• Q2 revenue increased 37% year over year to $4.2 million, driven largely by the acquired Nanox Health IT business and continued growth in teleradiology, which averaged 14% year-over-year growth in the first half of 2026.
• Financial losses and liquidity pressures remain significant: adjusted EBITDA loss widened to $11.3 million, cash and restricted deposits fell to $31.4 million from $60 million at year-end, and the company recorded a $40.7 million non-cash impairment charge. Nanox subsequently raised $8.5 million through equity offerings and said it expects to continue seeking additional capital.
• Management acknowledged that commercialization has taken longer than expected and announced workforce and manufacturing reductions, including a 15% cut among Israeli employees and a two-thirds reduction in Korea, where chip production was idled. The company expects about $2 million in annualized savings beginning in 2027, while shifting production to third-party suppliers and preparing to sell its Korean facility.

Nano-X Imaging Trading Down 4.0%

Shares of NASDAQ NNOX traded down $0.03 during midday trading on Friday, reaching $0.64. The company's stock had a trading volume of 795,024 shares, compared to its average volume of 1,529,712. The stock has a 50 day simple moving average of $0.85 and a 200-day simple moving average of $1.47. The stock has a market capitalization of $49.96 million, a price-to-earnings ratio of -0.30 and a beta of 1.28. Nano-X Imaging has a fifty-two week low of $0.63 and a fifty-two week high of $4.71.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on the company. Cantor Fitzgerald restated an "overweight" rating and set a $5.00 target price on shares of Nano-X Imaging in a research report on Monday, August 17th. Zacks Research upgraded Nano-X Imaging from a "strong sell" rating to a "hold" rating in a research report on Monday, June 22nd. Alliance Global Partners cut Nano-X Imaging from a "buy" rating to a "neutral" rating and lowered their price target for the company from $5.00 to $3.00 in a research note on Tuesday, July 7th. Finally, Weiss Ratings reaffirmed a "sell (e+)" rating on shares of Nano-X Imaging in a research note on Wednesday, July 8th. One equities research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, Nano-X Imaging currently has an average rating of "Moderate Buy" and a consensus target price of $4.33.

Insider Activity at Nano-X Imaging

In related news, Director Dan S. Suesskind acquired 60,000 shares of the company's stock in a transaction dated Monday, September 14th. The shares were bought at an average price of $0.76 per share, for a total transaction of $45,600.00. Following the purchase, the director directly owned 110,000 shares in the company, valued at approximately $83,600. This trade represents a 120.00% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Erez Meltzer acquired 36,000 shares of the business's stock in a transaction dated Monday, July 27th. The stock was bought at an average cost of $0.93 per share, with a total value of $33,480.00. Following the acquisition, the chief executive officer owned 36,000 shares in the company, valued at $33,480. The trade was a ∞ increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders have acquired a total of 175,443 shares of company stock worth $150,006 in the last ninety days. Insiders own 7.74% of the company's stock.

About Nano-X Imaging

Nano-X Imaging Ltd. NASDAQ: NNOX is an Israeli medical technology company focused on expanding access to diagnostic imaging. The company develops digital X-ray systems and related software intended to provide affordable, digitally managed imaging services for hospitals, clinics, and other healthcare providers.

Its principal platform, Nanox.ARC, is a digital X-ray system designed around a proprietary cold-cathode X-ray source and a multi-source imaging architecture. The company also offers Nanox.CLOUD, a cloud-based platform intended to connect imaging devices with radiologists and healthcare networks, and Nanox.AI, software designed to assist with the detection and prioritization of findings in medical images.

Nano-X markets its technologies to customers and partners in multiple international markets, with regulatory clearances and commercial availability varying by product and jurisdiction.